1 Product identity
Violet
Mineral Tablet or Pill 7 ingredients DSLD #80847Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2017-11-20
2 Ingredients (7)
IngredientGroupSafety
MannitolMannitol—
SorbitolSorbitol—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Iodine — Conditionally Safe
⚠ Thyroid dysfunction at excess
⚠ Kelp: variable content
Selenium — Conditionally Safe
⚠ Selenosis >400 mcg
⚠ Diabetes risk at high doses
Sodium — Conditionally Safe
⚠ Hypertension
⚠ Fluid retention
Sodium — Conditionally Safe
⚠ Hypertension
⚠ Fluid retention
Magnesium — Generally Safe
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID80847
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2017-11-20
6 More from BioPharmX
View BioPharmX Safety Scorecard → 2 products
Violet7 Cite this page
Vancouver
Pkhakadze G. Violet — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 May 30]. Available from: https://supplement.ge/products/violet-80847/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG